Citation

Wacker DA, Wang Y, Broekema M, Rossi K, O'Connor S, Hong Z, Wu G, Malmstrom SE, Hung CP, LaMarre L, Chimalakonda A, Zhang L, Xin L, Cai H, Chu C, Boehm S, Zalaznick J, Ponticiello R, Sereda L, Han SP, Zebo R, Zinker B, Luk CE, Wong R, Everlof G, Li YX, Wu CK, Lee M, Griffen S, Miller KJ, Krupinski J, Robl JA.: Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an antidiabetic clinical candidate targeting GPR119. J Med Chem, Volume 57 (18), 2014

Authors

Boehm S, Broekema M, Cai H, Chimalakonda A, Chu C, Everlof G, Griffen S, Han SP, Hong Z, Hung CP, Krupinski J, Lamarre L, Lee M, Li YX, Luk CE, Malmstrom SE, Miller KJ, O'Connor S, Ponticiello R, Robl JA., Rossi K, Sereda L, Wacker DA, Wang Y, Wong R, Wu CK, Wu G, Xin L, Zalaznick J, Zebo R, Zhang L, Zinker B

Journal

J Med Chem

Year

2014

DOI

10.1021/jm501175v

PubMed

25208139

Machine-readable

REST APIRDF